SAN FRANCISCO, June 3, 2022 /PRNewswire/ — ValGenesis Inc., the leader in enterprise validation lifecycle management software, today announced that a European multinational consumer products company has selected the ValGenesis Validation Lifecycle Management System (VLMS) to manage its enterprise validation lifecycle process. The company operates in around 60 countries and produces health, hygiene and nutrition products that are sold in almost 200 countries around the world.
ValGenesis has proven its depth of functionality and ease of use after a rigorous, month-long evaluation and selection process. The company, which owns a high-quality portfolio of antiseptics, analgesics, baby food and other popular household brands, applied comprehensive evaluation criteria to the supplier selection process. At the end of the evaluation process, ValGenesis VLMS was the clear winner.
This is the largest UK-based consumer goods company implementing ValGenesis VLMS. The system controls all of the company’s validation programs, including computer system validation (CSV) and equipment qualification. ValGenesis VLMS defines and enforces global validation standards and best practices across the enterprise while streamlining validation processes to meet the most stringent data integrity and regulatory requirements. The focus of the company is initially on the locations in IndiaUK and US will then be expanded to other global websites to 7500+ users when fully implemented.
ValGenesis pioneered paperless validation and created the ValGenesis VLMS, the industry’s first, proven, 100% paperless validation lifecycle management solution, trusted by hundreds of life science customers as their validation record system. ValGenesis VLMS covers the entire validation lifecycle process, delivering technology solutions that are validated, fully configurable and rapidly deployable via a validated private secured cloud. ValGenesis VLMS enables new levels of collaboration, data integrity, risk management and compliance within validation lifecycle management processes.
“With hundreds of life science companies using ValGenesis VLMS as a record system for validation programs, we are very excited to onboard our first multinational consumer products customer,” he says Steve Reynolds, Chief Revenue Officer at ValGenesis. “Our SaaS-based platform easily enables data integrity governance to meet the most stringent regulatory standards while accelerating the development and manufacturing of this client’s well-known brands for global markets. We look forward to working with them and helping them achieve their digital validation goals,” he explained.
ValGenesis, Inc. is the creator of an innovative software platform that serves as the foundation for managing compliance-based validation activities in life science companies. ValGenesis, Inc. is the provider of the first enterprise application that supports the enterprise validation lifecycle process. As the first completely paperless solution for 100% electronic management of validation execution and approval, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association’s (PDA) New Innovative Technology Award in 2005. The solution is also fully compliant with US FDA 21 CFR Part 11 and Annex 11 requirements.
For more information, visit https://www.valgenesis.com/
Althea D’Sylva, ValGenesis Communications, +1 510-445-0505 Ex. 1026, [email protected]
SOURCE ValGenesis Inc.